Caitong International Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Caitong International Asset Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4	Closed	-$131	–	2766
2025 Q4	$131	Buy	+4	New	+$129	﹤0.01%	1669
2025 Q3	–	Sell	-90	Closed	-$2.52K	–	2160
2025 Q2	$2.52K	Buy	90 +18	+25%	+$483	﹤0.01%	1307
2025 Q1	$1.81K	Buy	+72	New	+$1.82K	﹤0.01%	1391

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Caitong International Asset Management's LKFT Position: Q1 2026 in Review

Caitong International Asset Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2026, closing a stake of 4 shares — an estimated $131 sold.

Caitong International Asset Management first reported a position in LKFT in Q1 2025 and held it in 3 quarters. The position peaked at $2.52K in Q2 2025. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

Caitong International Asset Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2026 after selling out during the quarter.
Caitong International Asset Management sold 4 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $131.
Caitong International Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2025 and held it in 3 quarters.
Caitong International Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $2.52K in Q2 2025.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.